Ahead of the Bell: Alkermes upgraded on 3Q results (INO News)

More info…
(AP:NEW YORK) Strong sales of a schizophrenia drug during the third quarter prompted an analysts to upgrade shares of Alkermes Inc. on Friday. Shares jumped 10 percent, or $1.10, to $11.62 in premarket trading.

official drug abuse hotline

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • YahooMyWeb
  • Google Bookmarks
  • Yahoo! Buzz
  • TwitThis
  • Live
  • LinkedIn
  • Pownce
  • MySpace

Leave a Reply




Security Code: